Skip to main content
Erschienen in: Pediatric Cardiology 7/2013

01.10.2013 | Case Report

Response to a Single Dose of Sildenafil in Single-Ventricle Patients: An Echocardiographic Evaluation

verfasst von: Kimberly W. Jackson, Ryan J. Butts, Amy J. Svenson, Tim C. McQuinn, Andrew M. Atz

Erschienen in: Pediatric Cardiology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

New evidence of increased phosphodiesterase-5 (PDE-5) in hypertrophied human myocardium suggests that sildenafil, a selective PDE-5 inhibitor, may improve muscle contraction and therefore improve ventricular function. The purpose of this study was to compare ventricular function as assessed by echocardiography in 10 surgically palliated single-ventricle patients at baseline and again after a single dose of sildenafil. The velocity time integral of the ventricular outflow tract was increased 2 h after sildenafil administration (p = 0.01), thus suggesting an improvement in cardiac output.
Literatur
1.
Zurück zum Zitat Botha P, Parry G, Dark JH, Macgowan GA (2009) Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. J Heart Lung Transplant 28(7):676–682CrossRefPubMed Botha P, Parry G, Dark JH, Macgowan GA (2009) Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. J Heart Lung Transplant 28(7):676–682CrossRefPubMed
2.
Zurück zum Zitat Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM (2008) Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 29(13):1681–1687CrossRefPubMed Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM (2008) Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 29(13):1681–1687CrossRefPubMed
3.
Zurück zum Zitat Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD et al (2011) Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123(11):1185–1193PubMedCentralCrossRefPubMed Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD et al (2011) Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123(11):1185–1193PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Jung SY, Seo YG, Kim GK, Woo JS, Yong CS, Choi HG (2011) Comparison of the solubility and pharmacokinetics of sildenafil salts. Arch Pharm Res 34(3):451–454CrossRefPubMed Jung SY, Seo YG, Kim GK, Woo JS, Yong CS, Choi HG (2011) Comparison of the solubility and pharmacokinetics of sildenafil salts. Arch Pharm Res 34(3):451–454CrossRefPubMed
5.
Zurück zum Zitat Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ (2010) Changing mortality in congenital heart disease. J Am Coll Cardiol 56(14):1149–1157CrossRefPubMed Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ (2010) Changing mortality in congenital heart disease. J Am Coll Cardiol 56(14):1149–1157CrossRefPubMed
6.
Zurück zum Zitat Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A et al (2007) Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 116(3):238–248CrossRefPubMed Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A et al (2007) Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 116(3):238–248CrossRefPubMed
7.
Zurück zum Zitat Raja SG, Danton MD, MacArthur KJ, Pollock JC (2006) Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence. J Cardiothorac Vasc Anesth 20(5):722–735CrossRefPubMed Raja SG, Danton MD, MacArthur KJ, Pollock JC (2006) Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence. J Cardiothorac Vasc Anesth 20(5):722–735CrossRefPubMed
8.
Zurück zum Zitat Reinhardt Z, Uzun O, Bhole V, Ofoe V, Wilson D, Onuzo O et al (2010) Sildenafil in the management of the failing Fontan circulation. Cardiol Young 20(5):522–525CrossRefPubMed Reinhardt Z, Uzun O, Bhole V, Ofoe V, Wilson D, Onuzo O et al (2010) Sildenafil in the management of the failing Fontan circulation. Cardiol Young 20(5):522–525CrossRefPubMed
9.
Zurück zum Zitat Sundareswaran KS, Pekkan K, Dasi LP, Whitehead K, Sharma S, Kanter KR et al (2008) The total cavopulmonary connection resistance: a significant impact on single ventricle hemodynamics at rest and exercise. Am J Physiol Heart Circ Physiol 295(6):H2427–H2435PubMedCentralCrossRefPubMed Sundareswaran KS, Pekkan K, Dasi LP, Whitehead K, Sharma S, Kanter KR et al (2008) The total cavopulmonary connection resistance: a significant impact on single ventricle hemodynamics at rest and exercise. Am J Physiol Heart Circ Physiol 295(6):H2427–H2435PubMedCentralCrossRefPubMed
Metadaten
Titel
Response to a Single Dose of Sildenafil in Single-Ventricle Patients: An Echocardiographic Evaluation
verfasst von
Kimberly W. Jackson
Ryan J. Butts
Amy J. Svenson
Tim C. McQuinn
Andrew M. Atz
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2013
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0415-4

Weitere Artikel der Ausgabe 7/2013

Pediatric Cardiology 7/2013 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.